These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37954501)

  • 1. Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial.
    Pasilan RM; Pawar N; Alawieh R; Hiremath S; Teakell J
    Kidney Med; 2023 Dec; 5(12):100739. PubMed ID: 37954501
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
    Dhayat NA; Faller N; Bonny O; Mohebbi N; Ritter A; Pellegrini L; Bedino G; Schönholzer C; Venzin RM; Hüsler C; Koneth I; Del Giorno R; Gabutti L; Amico P; Mayr M; Odermatt U; Buchkremer F; Ernandez T; Stoermann-Chopard C; Teta D; Rintelen F; Roumet M; Irincheeva I; Trelle S; Tamò L; Roth B; Vogt B; Fuster DG
    BMC Nephrol; 2018 Dec; 19(1):349. PubMed ID: 30526528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE).
    Chen DC; McVey A; Murphy DG; Eapen R; Lawrentschuk N
    Eur Urol; 2023 Sep; 84(3):353-354. PubMed ID: 37236856
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of nephrolithiasis - Preliminary results of the Swiss Kidney Stone Cohort (SKSC) and the NOSTONE trial].
    Stritt K; Bosshard P; Bonny O; Roth B
    Rev Med Suisse; 2020 Dec; 16(717):2317-2320. PubMed ID: 33263954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
    Dhayat NA; Bonny O; Roth B; Christe A; Ritter A; Mohebbi N; Faller N; Pellegrini L; Bedino G; Venzin RM; Grosse P; Hüsler C; Koneth I; Bucher C; Del Giorno R; Gabutti L; Mayr M; Odermatt U; Buchkremer F; Ernandez T; Stoermann-Chopard C; Teta D; Vogt B; Roumet M; Tamò L; Cereghetti GM; Trelle S; Fuster DG
    N Engl J Med; 2023 Mar; 388(9):781-791. PubMed ID: 36856614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leave NOSTONE unturned: are thiazides useless in preventing kidney stone recurrence?
    Brazier F; Cornière N; Eladari D
    Kidney Int; 2023 Oct; 104(4):640-643. PubMed ID: 37437809
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
    Hsi RS; Tasian G; Maalouf NM
    N Engl J Med; 2023 May; 388(21):2014-2015. PubMed ID: 37224212
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
    Lyall VS; Wood KD; Pais VM
    N Engl J Med; 2023 May; 388(21):2014. PubMed ID: 37224211
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
    Knebelmann B; Haydock L
    N Engl J Med; 2023 May; 388(21):2013-2014. PubMed ID: 37224210
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. Reply.
    Fuster DG; Bonny O; Roth B
    N Engl J Med; 2023 May; 388(21):2015-2016. PubMed ID: 37224213
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of hydrochlorothiazide on kidney stone therapy with extracorporeal shock wave lithotripsy.
    Tehranchi A; Rezaei Y; Mohammadi-Fallah M; Mokhtari M; Alizadeh M; Abedi F; Khalilzadeh M; Tehranchi P
    Urol Ann; 2014 Jul; 6(3):208-11. PubMed ID: 25125892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study.
    Solak V; Gökce Mİ; Yaman Ö
    Int Urol Nephrol; 2021 Sep; 53(9):1791-1796. PubMed ID: 33904027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big trials in prostate cancer | predicting drug response in bladder cancer | immune checkpoint inhibitors for urothelial carcinoma | hydrochlorothiazide in the prevention of kidney stone recurrence.
    BJU Int; 2023 Jul; 132(1):2-3. PubMed ID: 37340815
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-Term Adherence to Medications in Secondary Prevention of Urinary Tract Stones.
    Golomb D; Nevo A; Goldberg H; Ehrlich Y; Margel D; Lifshitz D
    J Endourol; 2019 Jun; 33(6):469-474. PubMed ID: 30909741
    [No Abstract]   [Full Text] [Related]  

  • 15. Voclosporin for Lupus Nephritis: A #NephJC Editorial on AURORA.
    Auguste B; Teakell J; Ullur AR; Topf JM; Hiremath S
    Kidney Med; 2021; 3(6):889-892. PubMed ID: 34938997
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroids for IgA Nephropathy: A #NephJC Editorial on the TESTING trial.
    Chellappan A; Kermond R; Caza T; Teakell J; Hiremath S
    Kidney Med; 2022 Dec; 4(12):100565. PubMed ID: 36438023
    [No Abstract]   [Full Text] [Related]  

  • 17. Lanthanum in Dialysis, the LANDMARK Trial: A #NephJC Editorial.
    Trinidad CNB; Hanna MG; Ramesh S; Topf JM; Hiremath S
    Kidney Med; 2022 Feb; 4(2):100402. PubMed ID: 35243312
    [No Abstract]   [Full Text] [Related]  

  • 18. Balanced Solutions Versus Saline to Reduce AKI: A #NephJC Editorial on the BaSICS Trial.
    Shankar M; Trinidad C; Tannor EK; Hiremath S; Topf JM
    Kidney Med; 2022 Jun; 4(6):100472. PubMed ID: 35620080
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones.
    Wolfgram DF; Gundu V; Astor BC; Jhagroo RA
    Urolithiasis; 2013 Aug; 41(4):315-22. PubMed ID: 23660825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium-Enriched Salt to Lower Stroke Risk: A #NephJC Editorial on the SSaSS Study.
    Shimamura Y; Turk M; Qader MA; Shah S; Topf JM; Hiremath S
    Kidney Med; 2022 Jul; 4(7):100489. PubMed ID: 35801189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.